YD Bio Limited Ordinary Shares
YDES · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $41,050 | $41,165 | $48,566 | $48,566 |
| - Cash | $6 | $0 | $102 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $41,044 | $41,164 | $48,464 | $48,566 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2,216 | -$3,366 | $418 | $2,178 |
| % Margin | – | – | – | – |
| Net Income | -$2,215 | -$3,368 | $418 | $2,190 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.65 | -0.98 | 0.1 | 0.54 |
| % Growth | 33.7% | -1,080% | -81.5% | – |
| Operating Cash Flow | -$298 | -$490 | -$366 | -$22 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$298 | -$490 | -$366 | -$22 |